MHC跨表型关联分析识别区分银屑病关节炎与银屑病的遗传变异
研究对2808例单纯皮肤银屑病患者、1945例银屑病关节炎患者和8920例人群对照进行MHC区SNP、氨基酸及经典HLA等位基因插补和关联分析。结果显示HLA-C*06:02对银屑病关节炎相对单纯皮肤银屑病有保护作用(p=9.57×10-66,OR 0.37),且与更早的银屑病发病年龄相关。控制发病年龄后,HLA-C*06:02与银屑病关节炎无关联(p=0.07),而HLA-B第97位氨基酸(天冬酰胺或丝氨酸)成为最显著关联,可区分银屑病关节炎与单纯皮肤银屑病。
要点
- HLA-C*06:02相对单纯皮肤银屑病对银屑病关节炎有保护作用(OR 0.37)。
- 控制银屑病发病年龄后,HLA-C*06:02与银屑病关节炎无关联(p=0.07)。
- HLA-B第97位天冬酰胺或丝氨酸增加银屑病关节炎风险,可区分两表型。
核心结论
- 控制银屑病发病年龄后,HLA-C*06:02与银屑病关节炎无关联,HLA-B第97位氨基酸可区分银屑病关节炎与单纯皮肤银屑病。
- HLA-B第97位氨基酸也是强直性脊柱炎最大的遗传效应, refined 两种脊柱关节炎的遗传重叠。
研究设计与样本
- 纳入2808例单纯皮肤银屑病患者、1945例银屑病关节炎患者和8920例人群对照进行基因分型。
- 对MHC区SNP、氨基酸及经典HLA等位基因进行插补,并与人群对照及单纯皮肤银屑病患者组比较关联。
- 还分析了发病年龄对关联的影响。
主要发现
- HLA-C*06:02相对单纯皮肤银屑病对银屑病关节炎有保护作用(p=9.57×10-66,OR 0.37)。
- HLA-C*06:02风险等位基因与所有患者中更年轻的银屑病发病年龄相关(p=1.01×10-59)。
- 控制银屑病发病年龄后,银屑病关节炎与HLA-C*06:02无关联(p=0.07)。
- 控制发病年龄后,最显著关联为HLA-B第97位氨基酸(p=1.54×10-9),天冬酰胺或丝氨酸残基增加银屑病关节炎风险。
- HLA-B第97位天冬酰胺定义HLA-B*27等位基因。
关键数值与推荐
- HLA-C*06:02与银屑病关节炎比较单纯皮肤银屑病:p=9.57×10-66,OR 0.37。
- HLA-C*06:02与银屑病发病年龄:p=1.01×10-59。
- 控制发病年龄后HLA-C*06:02与银屑病关节炎:p=0.07。
- 控制发病年龄后HLA-B第97位氨基酸与银屑病关节炎:p=1.54×10-9。
临床怎么用
- 在银屑病患者中评估HLA-B第97位氨基酸(尤其HLA-B*27相关天冬酰胺)有助于区分银屑病关节炎与单纯皮肤银屑病。
- 解释HLA-C*06:02与银屑病关节炎的关联时需考虑银屑病发病年龄的混杂影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Psoriatic arthritis (PsA) is a chronic inflammatory arthritis, with a strong heritable component, affecting patients with psoriasis. Here we attempt to identify genetic variants within the major histocompatibility complex (MHC) that differentiate patients with PsA from patients with cutaneous psoriasis alone (PsC). METHODS: 2808 patients with PsC, 1945 patients with PsA and 8920 population controls were genotyped. We imputed SNPs, amino acids and classical HLA alleles across the MHC and tested for association with PsA compared to population controls and the PsC patient group. In addition we investigated the impact of the age of disease onset on associations. RESULTS: HLA-C*06:02 was protective of PsA compared to PsC (p=9.57×10-66, OR 0.37). The HLA-C*06:02 risk allele was associated with a younger age of psoriasis onset in all patients (p=1.01×10-59). After controlling for the age of psoriasis onset no association of PsA to HLA-C*06:02 (p=0.07) was observed; instead, the most significant association was to amino acid at position 97 of HLA-B (p=1.54×10-9) where the presence of asparagine or serine residue increased PsA risk. Asparagine at position 97 of HLA-B defines the HLA-B*27 alleles. CONCLUSIONS: By controlling for the age of psoriasis onset, we show, for the first time, that HLA-C*06:02 is not associated with PsA and that amino acid position 97 of HLA-B differentiates PsA from PsC. This amino acid also represents the largest genetic effect for ankylosing spondylitis, thereby refining the genetic overlap of these two spondyloarthropathies. Correcting for bias has important implications for cross-phenotype genetic studies.
引用
- Bowes J, Ashcroft J, Dand N, et al. Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis. Ann Rheum Dis. 2017. PMID: 28821532. doi:10.1136/annrheumdis-2017-211414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。